Partnering opportunity

Cost-efficient molecular point of care diagnostic platform for environmental/food safety testing and dental diagnostics


A German SME experienced in molecular diagnostics has developed a poprietary cartridge-based sample-to-answer point-of-care diagnostic platform. In contrast to conventional methods "laymen" can carry out laboratory analysis because after sample dispensing the process runs automated. The result is available in 30-60 minutes. Industrial partners from the field of analytics/ diagnostics of e.g. food and beverage, environment (e.g. Legionella in water) are sought for licensing/commercial agreement.

Partner sought

The German SME is looking for industrial partners from the field of e.g. analytics, diagnostics, food & beverage, water etc. for licensing-in or acquisition of the technology under a commercial agreement. With acquisition of the technology a complete transfer of the technology including all rights for certain fields of application is meant. This could be done in the form of an asset deal - comparable to their asset deal in the end of 2016 for selling the technology platform for clinical applications. They are also open to other forms of co-operation. The task to be performed from the partner sought is commercialization of the diagnostic POC platform in the fields of food & beverage, water (e.g. Legionella), environmental analytics and, as the case may be, dental diagnostics. The German SME supports with adaptation of the partner's field of application to the technology platform. The German company can provide manufacturing of the complete technology platform (consisting of instruments and plastic disposable cartridges) by using the services of a qualified and specialized OEM manufacturer.


Molecular diagnostics is important, among others, in the field of health, food safety and environment. In the clinical field it provides a reliable aid for deision-making in treatment of patients. The problem of conventional centralized diagnostics is that it takes several hours up to some days. That means that it is time consuming, more staff is needed which has to be instructed or trained and thus costs arise. A German SME active in the field of molecular diagnostics for about 17 years offers an innovative solution for rapid molecular diagnostics: It has developed a proprietary cartridge-based sample-to-answer point-of-care (POC) diagnostic platform which is based on integrated DNA/RNA (ribonucleic acid) extraction and qPCR (quantitative polymerase chain reaction). The benchmarking platform delivers rapid, easy-to-use and highly specific and sensitive pathogen and genetic marker diagnostics. Only semi-skilled staff is necessary to carry out a laboratory analysis. After the sample is dispensed the process runs automated and already shows results after 30-60 minutes. That means - in a clinical application field- already during the patient appointment. The point of care diagnostic platform can be applied in a broad range of clinical applications, for example dental testing and industrial applications, such as testing food safety, environmental issues, e.g. water. The worldwide rights for the non-clinical applications of the platform (environmental, water and food safety testing) as well as dental diagnostics are available for licensing projects or acquisition meaning a commercial agreement. Last mentioned would comprise a complete transfer of the technology including all rights, e.g. in form of an asset deal. The German SME is also open to other forms of co-operation. Industrial partners from the application areas mentioned before are sought for licensing/acquisition of the technology. The inventor would help to adjust the solution to the partner´s/acquirer's requirements. Manufacturing of the complete system (instrument plus disposable cartridges) can be provided through the services of a qualified and specialized OEM (= original equipment manufacturer).

Advantages and innovations

- in comparision to conventional methods which need several hours until days here results are available in 30-60 minutes - easy-to-use and - in contrast to other methods - only semi-skilled staff is necessary (human resource efficiency) - highly specific - sample-to-answer qPCR diagnostics - sensitive and quantitative pathogen and genetic marker diagnostics - highly cost-efficient - very flexible, can be applied in a broad range of applications - pathogen diagnostics, not dependent on viable cells (VBNC detection = viable but non-culturable)

Development stage

Available for demonstration

Intellectual Property Rights (IPR)

Exclusive Rights

Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company